Paul Carlson

Company: FDA
Job title: Principal Investigator
Seminars:
Regulatory Considerations for Microbiome-based Therapeutics 9:00 am
• Overview of investigational new drug protocol requirements • CMC considerations for live biotherapeutic products • CMC considerations for fecal transplant based productsRead more
day: Day Two